Sponsor:
Adlai Nortye Biopharma Co., Ltd.
Code:
NCT04999384
Conditions
Advanced Solid Tumor
Advanced Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AN4005-dose level 0
AN4005-dose level 1
AN4005-dose level 2
AN4005-dose level 3
AN4005-dose level 4
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by Adlai Nortye Biopharma Co., Ltd. on 2024-10-24.